Delivery Order SPE2DB20D1100-SPE2DB24FB0L4
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $1,111.44 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of ULTANE 250 ML PEN BOTTLE 250ML pharmaceutical products and has a performance period through March 29, 2024. Amerisourcebergen Drug Corp also holds an indefinite delivery contract (IDC) from DLA valued up to $999,999,999.00 through December 31, 2025. This IDC serves as the...
- This federal contract award, valued at $1,203.25, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Ultane 250 ML Pen Bottles. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 30, 2025. Amerisourcebergen Drug Corp is the prime contractor, and the contract is not designated as a set-aside. This award is part of a larger Indefinite Delivery Contract (IDC) that...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the delivery of ULTANE 250 ML PEN BOTTLE 250ML products, with a potential value of $3,027.66 and a completion date of February 21, 2024. Amerisourcebergen Drug Corp is the prime contractor, and no set-aside designation was used. This...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,828.94 to AmerisourceBergen Drug Corp for the supply of Ultane 250 mL pen bottles. This firm fixed-price, non-set-aside contract was awarded on June 16, 2025, with an ultimate completion date of June 17, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, is well-positioned to fulfill this...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,686.99, is for the delivery of Ultane 250 ML Pen Bottles. The contract has a completion date of February 7, 2025, and is a firm fixed-price contract. Amerisourcebergen Drug Corp is a for-profit organization registered in the System for Award Management (SAM.gov) and has a...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $1,667.16 firm fixed-price delivery order contract to AmerisourceBergen Drug Corp's Corporate Office division. This contract is for the supply of 4565818463 ULTANE 250 ML PEN BOTTLE 250ML, a pharmaceutical product, with an ultimate completion date of September 17, 2024. The contract is not set aside and serves as a delivery order against a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 between...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,155.12, is for the supply of Ultane 250 ML Pen Bottles, a medical product used in healthcare settings. The contract is a Firm Fixed Price arrangement, without any set-aside designation, and has a completion date of February 18, 2025. AmerisourceBergen holds a significant Indefinite Delivery...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $4,679.89 on September 17, 2025, for the supply of Ultane 250 ML in pen bottle format. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 18, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,706.01 firm fixed-price delivery order is for the supply of Ultane Liquid, a 250 mL medication. The contract has a performance period through May 2025 and is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has been awarded a competitive delivery order valued at $1,155.12 by the Defense Logistics Agency (DLA) for Ultane 250 ml in pen bottle format. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of November 12, 2025, and was competitively awarded without a set-aside designation. This award represents a continuation of AmerisourceBergen's role as a critical pharmaceutical...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB24FB0L4Delivery Order
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide the pharmaceutical product Ultane 250 ML Pen Bottle 250ML. The contract has a ceiling value of $2,778.60 and a period of performance through April 2, 2024. This award is part of a larger indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp, which has a potential value of up to $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary vehicle for Amerisourcebergen Drug Corp to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. No set-aside designations were used for this contract.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.8k | 4/1/24 |